Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,960 | 11,954 | 19,390 | 26,616 | 125,298 |
| Marketable Securities | 112,904 | 113,209 | 133,774 | 143,953 | 79,194 |
| Receivables | 6,298 | 7,531 | 6,500 | 3,338 | 2,489 |
| TOTAL | $128,568 | $135,567 | $162,223 | $176,535 | $209,946 |
| Non-Current Assets | |||||
| PPE Net | 9,633 | 8,522 | 9,273 | 9,926 | 10,934 |
| Investments And Advances | 15,609 | 25,223 | 15,062 | 13,747 | 0 |
| Other Non-Current Assets | 2,560 | 2,366 | 2,254 | 2,250 | 2,259 |
| TOTAL | $27,802 | $36,111 | $26,589 | $25,923 | $13,193 |
| Total Assets | $156,370 | $171,678 | $188,812 | $202,458 | $223,139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,000 | 5,843 | 5,806 | 5,766 | 4,724 |
| Accounts payable and accrued liabilities | 5,584 | 4,549 | 4,516 | 3,395 | 3,061 |
| Accrued Expenses | 6,017 | 4,628 | 3,565 | 2,502 | 6,217 |
| Other current liabilities | 901 | 589 | 832 | 443 | 847 |
| TOTAL | $32,967 | $35,859 | $36,099 | $31,130 | $36,423 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,876 | 5,500 | 7,000 | 8,500 | 10,000 |
| Deferred Revenues | 19,465 | 20,250 | 21,380 | 19,024 | 21,574 |
| Other Non-Current Liabilities | 134 | 129 | 125 | 121 | 102 |
| TOTAL | $25,614 | $25,913 | $33,158 | $40,610 | $55,177 |
| Total Liabilities | $58,581 | $61,772 | $69,257 | $71,740 | $91,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,310 | 2,309 | 2,293 | 2,293 | 2,293 |
| Common Shares | 23 | 23 | 23 | 23 | 23 |
| Retained earnings | -195,745 | -180,956 | -168,044 | -154,251 | -150,328 |
| Other shareholders' equity | 165 | 223 | 213 | 56 | -47 |
| TOTAL | $97,789 | $109,906 | $119,555 | $130,718 | $131,539 |
| Total Liabilities And Equity | $156,370 | $171,678 | $188,812 | $202,458 | $223,139 |